Membership of Asthma management guideline Committee

Transcription

1 Principle to document the membership of a guideline Committee and DOIs (to be uploaded as soon as the Committee is appointed; and updated at Scope Consultation; Guideline Consultation; and final publication) Links to include none Attachments to include none Info to include guideline title; member name, title, organisation; matter under discussion and DOI Membership of Asthma management guideline Committee The Committee will operate as an advisory Committee to NICE s Board, developing a guideline on the management of asthma. The terms of reference and standing orders for the Committee can be found in appendix D of Developing NICE guidelines: the manual. The Committee has 12 members.

2 Membership list Agreed Constituency Name Job Title, Organisation Comment Chair John Alexander Consultant in Paediatric & Paediatric Intensive Care, Royal Stoke Members Noel Baxter General Practitioner, NHS Southwark CCG Andrew Bush Professor of Paediatrics & Head of Section, Royal Brompton & Harefield NHS Foundation Trust Susan Frost Lead Nurse Specialist, Birmingham Children's Chris Griffiths Principal in General Practice & Professor of Primary Care, Queen Mary of London Helen Haley Pharmacist in Child Health, s of North Midlands

3 Co-opted members Val Hudson Matt Masoli Nicola Mundy Prunella Neale Ellen Nicholson Stephen Scott Lindsay Apps Charlotte Church Kevin Gruffydd- Jones Patient Member Consultant Physician, Plymouth s NHS Trust Patient Member Practice Nurse, Herschel Medical Centre Senior Nurse Specialist, Homerton Foundation Trust Consultant Physician, Countess of Chester Practitioner Health Psychologist, Leicester General Physiotherapist in Asthma, Southampton NHS Foundation Trust Principal in General Practice, Box Surgery Date last reviewed: 09/11/2016

4 Declaration of Interests The effective management of conflicts of interests is an essential element in the development of the guidance and advice that NICE publishes. Please refer to the NICE website for the Policy on Conflicts of Interest. Name Job title, organisation Declarations of Interest, date declared Type of interest Decision taken

5 John Alexander Consultant in Paediatric & Paediatric Intensive Care, Royal Stoke In 2014 received payments from Abbvie for an advisory board and giving a talk, JAl s Trust paediatric respiratory team had two time out days on 10 July 2014 and 13 November 2014 which was facilitated by organisational development professionals from GSK, non- Nonpersonal Asked to give a talk on the management of life threatening asthma to our West Midlands Paediatric forum aimed at DGH paediatricians. The forum is sponsored through an arm s length educational grant from GSK which pays for room hire and lunch. The money for the room hire went directly to the venue. There are no speaker fees or expenses paid, Nonpersonal Chaired a clinical forum discussing the use of High Flow Nasal Cannula Oxygen treatment in children with respiratory distress. There were presentations and discussion from Reasonable travel expenses

6 Noel Baxter Andrew Bush General Practitioner, NHS Southwark CCG Professor of Paediatrics & Head of Section, Royal Brompton & Harefield NHS Foundation Trust local and international experts. Travel Expenses (industry standard mileage) and hotel accommodation for all attendees was paid for by Fisher Paykel, one of the companies that manufacture devices that deliver High Flow oxygen. Did not receive any fees., 16/02/2016 Executive member of PCRS-UK and an Asthma UK Council of Health Professionals member, Earns a small sum from book royalties, Will cease to be Editor in Chief of Thorax, from which I have no personal gain, in 2015, non- No contact with pharmaceutical companies, N/A N/A Inherited a small number of shares but none medically pertinent, non- Susan Frost Lead Nurse Specialist, Birmingham Children's Chair of the National Paediatric and Allergy Nurses Group (NPRANG). The NPRANG apply Nonpersonal

7 for annual educational grants from pharma companies, the last being from Novartis. SF is not a signatory for NPRANG funds only the treasurer and vice treasurer are. Any grants/payments are paid to NPRANG to the treasurer. The NPRANG also holds annual conferences where pharmaceutical companies pay to have a stand to display to all NPRANG members, On an evidence review group member for the BTS/SIGN guidelines for asthma, As Chair of National Paediatric and Allergy Nurses Group (NPRANG) we are currently organising our next national conference. Pharma companies are being approached by one of our committee members who is responsible for pharma liaison. If they agree to sponsor our conference, they are offered a stand at the event. Nonpersonal

8 Chris Griffiths Helen Haley Val Hudson Principal in General Practice & Professor of Primary Care, Queen Mary of London Pharmacist in Child Health, s of North Midlands Patient member This is purely an educational event however as this is our 20th year celebrations Airsonett have given a donation towards our evening celebratory event where 80 Paediatric and Allergy Nurses from across the UK will be attending for a pre-conference dinner. They have asked for a 10 minutes session on the evening to talk about Airsonett. The other pharma companies payments are pooled to fund the conference and will paid directly into NPRANG s bank account, 12/07/2016 Chair of an evidence review group on the BTS/SIGN guideline, None. N/A N/A In April 2015 she was asked by Praxel if she would speak as a person with asthma about the challenges of using inhalers to Boehringer Ingelheim Respimat Reasonable travel expenses

9 Consultancy Board Meeting in Amsterdam at very short notice because the Dutch patient had dropped out at the last minute. Praxel arranged standard class same day return flights for VH. VH was not expecting payment but received a large bouquet of flowers from Praxel the following week as a thank you, Attended a similar event in Berlin in April Praxel arranged standard class flights and VH was accommodated in the conference venue. VH did not receive payment for this, 07/07/2016 On Monday 6th September I attended the ERS Annual Meeting as a delegate. My registration fee of 335 Euros was paid for by Owlstone Medical who asked me to attend their discussion on Contributing to the design of a clinical trial on stratification in asthma through breath analysis as a patient representative. My accommodation and travel expenses were paid by Reasonable travel expenses Reasonable travel expenses

10 Asthma UK as I attended other meetings outside the Conference Centre on their behalf, 04/10/2016 Matt Masoli Consultant Physician, Plymouth s NHS Trust Preceptorship to attend Bronchial thermoplasty training at Wythenshaw Manchester with Dr R Niven in December Travel expenses supported by Boston Scientific, non- Involved as a local PI for a number of clinical trials in severe asthma including Mepolizumab, Benralizumab and lebrikizumab which are conducted by GSK, Astra-Zeneca and Roche respectively. Monies for trail involvement paid to the Trust R&D, 19/10/2015 Nonpersonal Nicola Mundy Prunella Neale Patient member Practice Nurse, Herschel Medical Centre Supported by Astra Zeneca to attend the European respiratory Society annual conference in September 2015, 19/10/2015 Reasonable travel expenses None. N/A N/A Undertook : Ipsos MORI telephone interview on behalf of NHS England non-

11 Subject : Recruitment and Retention of General Practice Nurses Fee : 50, 12/07/2016 Ellen Nicholson Senior Nurse Specialist, Homerton Foundation Trust Professional Educational funding from Boehringer Ingelheim for 2 day conference pass and associated travel to Winter British Thoracic Society Conference in London, 05/01/2016 Reasonable expenses Stephen Scott Consultant Physician, Countess of Chester Speaker at Teva Masterclass on Diagnostic Tools for Diseases 11/06/2016 at Hadley Wood, receiving no incentive for participation. Teva have combined this Masterclass with Napp Pharmaceutical Group Ltd., 14/06/2016 Declared that he has no personal interests to declare, Principal investigator for multicentre clinical trials involving Astra Zeneca, Boehringer Ingelheim, Novartis. SS is not sole signatory as the funds go through the Trust N/A Nonpersonal N/A

12 R&D, but has arranged for another consultant to become the signatory, Chair of the British Thoracic Society Asthma Specialist Advisory Committee, Previously a member of the Evidence Review Group for Delivery and Organisation of Care as part of the BTS / SIGN Asthma Guidelines, Currently joint chair of the Acute Management of Asthma evidence review group for the BTS/SIGN Asthma Guidelines and therefore part of the steering committee, I am secretary of the North West Thoracic Society. This position means I introduce speakers at the meetings for respiratory physicians in the North West. I have no direct pecuniary benefit from this and it is a voluntary/nominated position. It is a purely educational meeting

13 Lindsay Apps Charlotte Church Kevin Gruffydd- Jones Practitioner Health Psychologist, Leicester General Physiotherapist in Asthma, Southampton NHS Foundation Trust Principal in General Practice, Box Surgery with no presentations or input from pharma into the content of the meeting. However Boehringer do provide funding for the venue and catering but have no input into the speakers who are decided on by the secretary team. None. N/A N/A None. N/A N/A In the last 12months has acted as a consultant for, and received sponsorship to attend conferences from, various pharmaceutical companies. Declare and withdraw from review questions on pharmacological management. Declare and participate for nonpharmacological management as co-opted expert adviser. Acted as an expert reviewer of the BTS/SIGN Asthma guideline. Declare and participate

14 Date last reviewed: 09/11/2016